Ghaith Abu-Zeinah

17PUBLICATIONS

126CO-AUTHORS

Innate immunityHaematologyHaematological tumoursMedical microbiology not elsewhere classifiedRespiratory diseases

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (17)

Sort by Publication Date:

|Sep 16, 2026

Type 1 interferon perturbates clonal competition by reshaping human blood development.

|Jul 17, 2026

Cross-study analyses of the ropeginterferon alfa-2b effect on phlebotomy in low- and high-risk patients with polycythemia vera.

|May 22, 2026

Long-term outcomes of ropeginterferon alfa-2b-njft in polycythemia vera: a review of safety, efficacy, and potential disease modification.

|Apr 15, 2025

DNMT3A mutations are unlikely to affect interferon alfa treatment outcomes in patients with polycythemia vera.

Ghaith Abu-Zeinah, Katie Erdos, Neville Lee

|Dec 18, 2024

High pulmonary hypertension risk by echocardiogram shortens survival in polycythemia vera.

Alexander J Gazda, Di Pan, Katie Erdos

|Mar 20, 2024

Cytoreductive therapy in younger adults with polycythemia vera: a meta-analysis of safety and outcomes.

Reem S Chamseddine, Oleksandr Savenkov, Shehroz Rana

Pageof 3

Frequent Collaborators

Joseph Scandura

Richard T Silver

Daniel Choi

Federico Itri

Tobias Lahmer

Jon Salmanton-García

Francesco Marchesi

Shaimaa El-Ashwah

Marcio Nucci

Caroline Besson

Frequent Collaborators

Joseph Scandura

Richard T Silver

Daniel Choi

Federico Itri